Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 151 (6), 1186.e1-1186.e9
- https://doi.org/10.1016/j.ahj.2006.01.004
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJournal of the American College of Cardiology, 2004
- Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic AnginaA Randomized Controlled TrialJama-Journal Of The American Medical Association, 2004
- Intracellular Na+ regulation in cardiac myocytesCardiovascular Research, 2003
- Defective cardiac ion channels: from mutations to clinical syndromesJCI Insight, 2002
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)Journal of the American College of Cardiology, 2002
- Intracellular Sodium Accumulation During Ischemia as the Substrate for Reperfusion InjuryCirculation Research, 1999
- Sodium Regulation During Ischemia Versus Reperfusion and Its Role in InjuryCirculation Research, 1999
- Ranolazine Stimulates Glucose Oxidation in Normoxic, Ischemic, and Reperfused Ischemic Rat HeartsCirculation, 1996
- Ionic basis of ischaemic cardiac injury: insights from cellular studiesCardiovascular Research, 1994
- A persistent sodium current in rat ventricular myocytes.The Journal of Physiology, 1992